Artio Medical Closes $28M in Additional Series A Financing

Written By Alyssa Kolb

Artio Medical, Inc., the medical device company that is developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, announced this week the closing of $28 million in oversubscribed Series A2 and Series A3 financing. This brings the total amount raised to date to $74 million.

Artio is a Serra Capital III and Serra Capital III SBIC company.

Alyssa Kolb
Previous

OnRamp AgTech Conference Held in Champaign; Serra a Presenting Sponsor
Next

VeriSIM Life, Total Brain to develop drugs for broad range of neurological disorders